Report Detail
Global Competent Cells Market Size, Status and Forecast 2019-2025
- RnM3123976 |
- 19 March, 2019 |
- Global |
- 106 Pages |
- QYResearch |
- Other
Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.
Asia-Pacific has the largest global export quantity and manufacturers in Competent Cells market, while the North America is the second sales volume market for Competent Cells in 2016.
In the industry, Merck KGaA profits most in 2016 and recent years, while Thermo Fisher Scientific and Agilent Technologies ranked 2 and 3.The market share of them is 13.28%, 9.52% and 7.00% in 2016.The gap of market share is keep on enlarged due to different strategy.
Nowadays, there are two mainly types of Competent Cells, including Chemically Competent Cells and Electrocompetent Cells. And Chemically Competent Cells is the main type for Competent Cells, and the Chemically Competent Cells reached a sales volume of approximately 42236 K Unit in 2016, with 64.12% of global sales volume.
Competent Cells technology is much mature now, and new enterprises can not surpass existing famous brands on reputation or design in the short term. So, the study group recommends the new entrants need to be considered carefully before enter into this field.
In 2018, the global Competent Cells market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Competent Cells status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Competent Cells development in United States, Europe and China.
The key players covered in this study
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
GCC Biotech
SMOBIO Technology
Edge BioSystems
Market segment by Type, the product can be split into
Chemically Competent Cells
Electrocompetent Cells
Market segment by Application, split into
Subcloning & Routine Cloning
Phage Display Library Construction
Toxic/Unstable DNA Cloning
High-Throughput Cloning
Protein Expression
Mutagenesis
Single-Stranded DNA Production
Bacmid creation
Cre-lox recombination (PIR1/PIR2)
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Competent Cells status, future forecast, growth opportunity, key market and key players.
To present the Competent Cells development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Competent Cells are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Competent Cells Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Chemically Competent Cells
- 1.4.3 Electrocompetent Cells
- 1.5 Market by Application
- 1.5.1 Global Competent Cells Market Share by Application (2014-2025)
- 1.5.2 Subcloning & Routine Cloning
- 1.5.3 Phage Display Library Construction
- 1.5.4 Toxic/Unstable DNA Cloning
- 1.5.5 High-Throughput Cloning
- 1.5.6 Protein Expression
- 1.5.7 Mutagenesis
- 1.5.8 Single-Stranded DNA Production
- 1.5.9 Bacmid creation
- 1.5.10 Cre-lox recombination (PIR1/PIR2)
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Competent Cells Market Size
- 2.2 Competent Cells Growth Trends by Regions
- 2.2.1 Competent Cells Market Size by Regions (2014-2025)
- 2.2.2 Competent Cells Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 Competent Cells Market Size by Manufacturers
- 3.1.1 Global Competent Cells Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Competent Cells Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Competent Cells Market Concentration Ratio (CR5 and HHI)
- 3.2 Competent Cells Key Players Head office and Area Served
- 3.3 Key Players Competent Cells Product/Solution/Service
- 3.4 Date of Enter into Competent Cells Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Competent Cells Market Size by Type (2014-2019)
- 4.2 Global Competent Cells Market Size by Application (2014-2019)
5 United States
- 5.1 United States Competent Cells Market Size (2014-2019)
- 5.2 Competent Cells Key Players in United States
- 5.3 United States Competent Cells Market Size by Type
- 5.4 United States Competent Cells Market Size by Application
6 Europe
- 6.1 Europe Competent Cells Market Size (2014-2019)
- 6.2 Competent Cells Key Players in Europe
- 6.3 Europe Competent Cells Market Size by Type
- 6.4 Europe Competent Cells Market Size by Application
7 China
- 7.1 China Competent Cells Market Size (2014-2019)
- 7.2 Competent Cells Key Players in China
- 7.3 China Competent Cells Market Size by Type
- 7.4 China Competent Cells Market Size by Application
8 Japan
- 8.1 Japan Competent Cells Market Size (2014-2019)
- 8.2 Competent Cells Key Players in Japan
- 8.3 Japan Competent Cells Market Size by Type
- 8.4 Japan Competent Cells Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Competent Cells Market Size (2014-2019)
- 9.2 Competent Cells Key Players in Southeast Asia
- 9.3 Southeast Asia Competent Cells Market Size by Type
- 9.4 Southeast Asia Competent Cells Market Size by Application
10 India
- 10.1 India Competent Cells Market Size (2014-2019)
- 10.2 Competent Cells Key Players in India
- 10.3 India Competent Cells Market Size by Type
- 10.4 India Competent Cells Market Size by Application
11 Central & South America
- 11.1 Central & South America Competent Cells Market Size (2014-2019)
- 11.2 Competent Cells Key Players in Central & South America
- 11.3 Central & South America Competent Cells Market Size by Type
- 11.4 Central & South America Competent Cells Market Size by Application
12 International Players Profiles
- 12.1 Merck KGaA
- 12.1.1 Merck KGaA Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Competent Cells Introduction
- 12.1.4 Merck KGaA Revenue in Competent Cells Business (2014-2019)
- 12.1.5 Merck KGaA Recent Development
- 12.2 Thermo Fisher Scientific
- 12.2.1 Thermo Fisher Scientific Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Competent Cells Introduction
- 12.2.4 Thermo Fisher Scientific Revenue in Competent Cells Business (2014-2019)
- 12.2.5 Thermo Fisher Scientific Recent Development
- 12.3 Agilent Technologies
- 12.3.1 Agilent Technologies Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Competent Cells Introduction
- 12.3.4 Agilent Technologies Revenue in Competent Cells Business (2014-2019)
- 12.3.5 Agilent Technologies Recent Development
- 12.4 Takara Bio
- 12.4.1 Takara Bio Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Competent Cells Introduction
- 12.4.4 Takara Bio Revenue in Competent Cells Business (2014-2019)
- 12.4.5 Takara Bio Recent Development
- 12.5 Promega Corporation
- 12.5.1 Promega Corporation Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Competent Cells Introduction
- 12.5.4 Promega Corporation Revenue in Competent Cells Business (2014-2019)
- 12.5.5 Promega Corporation Recent Development
- 12.6 Beijing TransGen Biotech
- 12.6.1 Beijing TransGen Biotech Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Competent Cells Introduction
- 12.6.4 Beijing TransGen Biotech Revenue in Competent Cells Business (2014-2019)
- 12.6.5 Beijing TransGen Biotech Recent Development
- 12.7 GeneScript Corporation
- 12.7.1 GeneScript Corporation Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Competent Cells Introduction
- 12.7.4 GeneScript Corporation Revenue in Competent Cells Business (2014-2019)
- 12.7.5 GeneScript Corporation Recent Development
- 12.8 Yeastern Biotech
- 12.8.1 Yeastern Biotech Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Competent Cells Introduction
- 12.8.4 Yeastern Biotech Revenue in Competent Cells Business (2014-2019)
- 12.8.5 Yeastern Biotech Recent Development
- 12.9 New England Biolabs
- 12.9.1 New England Biolabs Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Competent Cells Introduction
- 12.9.4 New England Biolabs Revenue in Competent Cells Business (2014-2019)
- 12.9.5 New England Biolabs Recent Development
- 12.10 QIAGEN N.V.
- 12.10.1 QIAGEN N.V. Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Competent Cells Introduction
- 12.10.4 QIAGEN N.V. Revenue in Competent Cells Business (2014-2019)
- 12.10.5 QIAGEN N.V. Recent Development
- 12.11 OriGene Technologies
- 12.12 Lucigen
- 12.13 Zymo Research
- 12.14 Bio-Rad Laboratories
- 12.15 Bioline
- 12.16 Delphi Genetics
- 12.17 IBA GmBH
- 12.18 Cell Applications
- 12.19 BioDynamics Laboratory
- 12.20 Scarab Genomics
- 12.21 GCC Biotech
- 12.22 SMOBIO Technology
- 12.23 Edge BioSystems
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Competent Cells . Industry analysis & Market Report on Competent Cells is a syndicated market report, published as Global Competent Cells Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Competent Cells market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
